Gonadotropin-releasing hormone and its analogs.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Annual Review of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.MED.45.1.391PMID 8198390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gonadotropin-releasing hormone-stimulated intracellular Ca2+ fluctuations and luteinizing hormone release can be uncoupled from inositol phosphate production.

  1992cited by this paper
• Sodium fluoride provokes gonadotrope desensitization to gonadotropin-releasing hormone (GnRH) and gonadotrope sensitization to A23187: evidence for multiple G proteins in GnRH action.

  1992cited by this paper
• Development of gonadotrope desensitization to gonadotropin-releasing hormone (GnRH) and recovery are not coupled to inositol phosphate production or GnRH receptor number.

  1992cited by this paper
• Maintenance of gonadotropin-releasing hormone (GnRH)-stimulated luteinizing hormone release despite desensitization of GnRH-stimulated cytosolic calcium responses.

  1992cited by this paper
• Caldesmon: a bifunctional (calmodulin and actin) binding protein which regulates stimulated gonadotropin release.

  1991cited by this paper
• Gonadotropin-releasing hormone and its analogues.

  1991cited by this paper
• Specific identification and subcellular localization of three calmodulin-binding proteins in the rat gonadotrope: spectrin, caldesmon, and calcineurin.

  1991cited by this paper
• Treatment of Endometriosis With a Long-Acting Gonadotropin-Releasing Hormone Agonist Plus Medroxyprogesterone Acetate

  1990cited by this paper
• Clinical review 4: Diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men.

  1990cited by this paper
• Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.

  1989cited by this paper
• Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.

  1989cited by this paper
• Gonadotropin and α-Subunit Responses to Chronic Gonadotropin-Releasing Hormone Analog Administration in Patients With Glycoprotein Hormone- Secreting Pituitary Tumors*

  1989cited by this paper
• Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome.

  1989cited by this paper
• Clinical appreciation of LHRH analogue formulations.

  1989cited by this paper
• Treatment of uterine leiomyomata: past, present and future.

  1989cited by this paper
• Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.

  1988cited by this paper
• Simultaneous measurement of luteinizing hormone (LH)-releasing hormone, LH, and follicle-stimulating hormone release in intact and short-term castrate rats.

  1988cited by this paper
• Impact of sex steroids and their suppression on skeletal growth and maturation

  1988cited by this paper
• Platelet activating factor induces dopamine release in PC-12 cell line.

  1988cited by this paper
• Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist.

  1988cited by this paper
• Suppression of the ovary using a gonadotropin releasing-hormone agonist prior to stimulation for oocyte retrieval.

  1987cited by this paper
• GnRH secretion throughout the ovine estrous cycle.

  1987cited by this paper
• Homologous desensitization with gonadotropin-releasing hormone (GnRH) also diminishes gonadotrope responsiveness to maitotoxin: a role for the GnRH receptor-regulated calcium ion channel in mediation of cellular desensitization.

  1987cited by this paper
• The molecular mechanism of action of gonadotropin releasing hormone (GnRH) in the pituitary.

  1987cited by this paper
• Treatment of prostate cancer with gonadotropin-releasing hormone agonists.

  1986cited by this paper
• Pharmacokinetics of gonadotropin-releasing hormone and its analogs.

  1986cited by this paper
• Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.

  1986cited by this paper
• Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone.

  1986cited by this paper
• Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective.

  1986cited by this paper
• Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.

  1986cited by this paper
• Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

  1985cited by this paper
• Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

  1985cited by this paper
• The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women.

  1985cited by this paper
• Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.

  1984cited by this paper
• Developmental changes in neuroendocrine regulation of gonadotropin secretion in gonadal dysgenesis.

  1983cited by this paper
• A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.

  1983cited by this paper
• Induction of ovulation with chronic intermittent (pulsatile) administration of Gn-RH in women with hypothalamic amenorrhoea.

  1983cited by this paper
• Selective inhibition of follicle-stimulating hormone secretion by estradiol. Mechanism for modulation of gonadotropin responses to low dose pulses of gonadotropin-releasing hormone.

  1983cited by this paper
• Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist.

  1983cited by this paper
• The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes.

  1982cited by this paper
• Pulsatile secretion of luteinizing hormone in children.

  1982cited by this paper
• Simultaneous measurement of luteinizing hormone-releasing hormone and luteinizing hormone release in unanesthetized, ovariectomized sheep.

  1982cited by this paper
• THE TEMPORAL RELATIONSHIP BETWEEN GONADOTROPIN RELEASING HORMONE (GnRH) AND LUTEINIZING HORMONE (LH) SECRETION IN OVARIECTOMIZED EWES1

  1982cited by this paper
• [Demonstration of the pulsatile secretion of LH-RH into hypophysial portal blood of ewes using an original technic for multiple samples].

  1982cited by this paper
• "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.

  1982cited by this paper
• Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone.

  1982cited by this paper
• Chronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism.

  1982cited by this paper
• Pulsatile secretion of gonadotropins in early infancy

  1981cited by this paper
• Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty.

  1980cited by this paper
• Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone.

  1979cited by this paper
• Peptide hormones and their analogues: distribution, clearance from the circulation, and inactivation in vivo.

  1978cited by this paper
• Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone

  1978cited by this paper

• Ovarian Developmental Characteristics and Hypothalamic Transcriptomic Analysis of P. leopardus Under Different Aquaculture Modes

  2026cites this paper
• Investigating the Effectiveness of a New Derivative of Lecirelin in Inducing Ovulation in Mice

  2025cites this paper
• Systematic Review on the Increase in Body Mass Index Percentiles in Girls With Central Precocious Puberty Receiving Gonadotropin‐Releasing Hormone Analogues

  2025cites this paper
• Use of Relugolix for the Prevention of Impending Oliguria and Progressive Renal Failure in a Suspected Case of Prostate Carcinoma

  2025cites this paper
• GnRH-driven FSH synthesis and secretion are modulated through circ-ptpn4 ceRNA sequestration of let-7b-5p miRNA, which negatively controls ELK1 expression.

  2025cites this paper
• Activity Changes of the Hypothalamus-Pituitary Hormonal Axis in Peripubertal Female Rats

  2025cites this paper
• Effect of GnRH Analog Therapy on Adult Height in Girls with Idiopathic Central Precocious Puberty

  2025cites this paper
• Androgen Deprivation Therapy and Salvage Radiotherapy in Post-Radical Prostatectomy Biochemical Recurrence of Prostate Cancer: Current Evidence

  2025cites this paper
• Gender differences in drug-induced precocious puberty: a real-world analysis of adverse event reports from the FDA FAERS database (2004–2024)

  2025cites this paper
• Protocols for Endometrial Preparation and Endometrial Pattern Before Embryo Transfer in Patients with Asherman Syndrome

  2025cites this paper
• Precocious Puberty and Benign Variants in Female Children: Etiology, Diagnostic Challenges, and Clinical Management

  2025cites this paper
• Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer

  2025cites this paper
• The Double-Edged Nature of the Gonadotropin-Releasing Hormone Agonist (GnRHa) Long Protocol: A Case of Paradoxical Ovarian Hyperstimulation During the Expected Downregulation Phase

  2025cites this paper
• Gonadotrophin-releasing hormone receptors in GtoPdb v.2025.3

  2025cites this paper
• Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review

  2025cites this paper
• GnRH agonist pretreatment for frozen embryo transfer among women with polycystic ovary syndrome: a narrow systematic review and meta-analysis of randomized controlled trials

  2024cites this paper
• Gonadotropins Regulate the mRNA Expression of Gonadotropin-Releasing Hormone and Its Receptors in the Mouse Ovary and Uterus

  2024cites this paper
• Progress in the Stereoselective Synthesis Methods of Pyrrolidine-Containing Drugs and Their Precursors

  2024cites this paper
• Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.

  2024cites this paper
• Management of Advanced Prostate Cancer With Relugolix: Illustrative Case Scenarios From an Advanced Practice Provider Perspective

  2024cites this paper
• Cost-effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients with Metastatic Prostate Cancer: A Societal Perspective.

  2024cites this paper
• Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989

  2024cites this paper
• A comprehensive review on the effects of sex hormones on chemotherapy-induced cardiotoxicity: are they lucrative or unprofitable?

  2024cites this paper
• Early investigational agents for the treatment of benign prostatic hyperplasia’

  2024cites this paper
• Clickable tryptophan modification for late-stage diversification of native peptides

  2024cites this paper
• Single nucleus/cell RNA-seq of the chicken hypothalamic-pituitary-ovarian axis offers new insights into the molecular regulatory mechanisms of ovarian development

  2024cites this paper
• Assessing hypothalamic pituitary gonadal function in reproductive disorders

  2023cites this paper
• Gonadotrophin-releasing hormone receptors in GtoPdb v.2023.1

  2023cites this paper
• The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer

  2023cites this paper
• Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: a randomized, double-blind, placebo-controlled phase 1 study

  2023cites this paper
• Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration

  2023cites this paper
• Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis

  2023influential citation
• Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.

  2023cites this paper
• Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer

  2023cites this paper
• Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea

  2023cites this paper
• Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis

  2023cites this paper
• Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer

  2023cites this paper
• Androgen deprivation therapy with leuprolide increases abdominal adiposity without causing cardiac dysfunction in middle-aged male mice: Effect of sildenafil.

  2023cites this paper
• New insights into the role of LH in early ovarian follicular growth: a possible tool to optimize follicular recruitment.

  2023cites this paper
• Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.

  2023cites this paper
• Kisspeptins and the Neuroendocrine Control of Reproduction: Recent Progress and New Frontiers in Kisspeptin Research.

  2022cites this paper
• No pubertal growth spurt, rapid bone maturation, and menarche post GnRHa treatment in girls with precocious puberty

  2022cites this paper
• Meta-analysis of the relation between irritable bowel syndrome and antibodies against endogenous gonadotropin-releasing hormone and its receptor

  2022cites this paper
• NGF and the Male Reproductive System: Potential Clinical Applications in Infertility

  2022cites this paper
• Influência do revestimento comestível a base de amido e cera de abelha na preservação da qualidade pós-colheita de tomates italianos

  2022cites this paper
• Agonist triggering in oocyte donation programs—Mini review

  2022cites this paper
• Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

  2022cites this paper
• Estrogens and progestins

  2022cites this paper
• Roles of Gonadotropin Receptors in Sexual Development of Medaka

  2022cites this paper
• Neonatal Hypoxic-Ischemic Encephalopathy: Perspectives of Neuroprotective and Neuroregenerative Treatments.

  2022cites this paper
• The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density

  2021cites this paper
• Gonadotrophin-releasing hormone receptors in GtoPdb v.2021.3

  2021cites this paper
• Early Puberty and Hormone Disruptors

  2021cites this paper
• GPCR's and Endocrinology

  2021cites this paper
• Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer

  2021cites this paper
• Current Knowledge on the Multifactorial Regulation of Corpora Lutea Lifespan: The Rabbit Model

  2021cites this paper
• Reduced FSH and LH action: implications for medically assisted reproduction

  2021cites this paper
• NGF Rescues Spermatogenesis in Azoospermic Mice

  2021cites this paper
• REPRODUCTIVE FUNCTION AND ANTITUMOR ACTIVITY: DIFFERENT ROLES FOR THE HYPOTHALAMIC HORMONE GnRH

  2020cites this paper
• Caulerpa lentillifera Polysaccharides-Rich Extract Reduces Oxidative Stress and Proinflammatory Cytokines Levels Associated with Male Reproductive Functions in Diabetic Mice

  2020cites this paper
• Is puberty delaying treatment 'experimental treatment'?

  2020cites this paper
• Kisspeptin/GnRH1 system in Leydig cells of horse (Equus caballus): Presence and function.

  2020cites this paper
• Gonadotropin-releasing hormone-Cu complex (Cu-GnRH) transcriptional activity in vivo in the female rat anterior pituitary gland.

  2020cites this paper
• Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions

  2020cites this paper
• A Review of the Complex Relationship between Irritable Bowel Syndrome and Infertility

  2020cites this paper
• Gnrh receptor gnrhr2bbα is expressed exclusively in lhb-expressing cells in Atlantic salmon male parr.

  2020cites this paper
• Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin [6-D-Phe]: Production, optimization and in vitro release behavior.

  2020cites this paper
• Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.

  2020cites this paper
• Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients.

  2020cites this paper
• Suppression of ovarian activity in a captive African Lion Panthera leo after deslorelin treatment

  2020cites this paper
• Adding Insult to Injury: Improving the Regenerative Capacity of the Aged Thymus Following Clinically Induced Damage

  2019cites this paper
• GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition

  2019cites this paper
• Controlled Ovarian Stimulation Protocols for IVF: From First IVF Baby in the United States and Beyond

  2019cites this paper
• Evaluation of 111In-Labeled GnRH-I Tracer for SPECT Tumor Imaging

  2019cites this paper
• Strategies to Improve Posttransplant Immunity

  2019cites this paper
• Allosteric modulation of G protein‐coupled receptors by amiloride and its derivatives. Perspectives for drug discovery?

  2019cites this paper
• GnRH Analogs (Mechanism, Past Studies, Drug Options, Use in Precocious Puberty, Use in Gender-Nonconforming Youth)

  2019cites this paper
• Weight management merits attention in women with infertility: a cross-sectional study on the association of anthropometric indices with hormonal imbalance in a Ghanaian population

  2019cites this paper
• Prokineticins and their G protein-coupled receptors in health and disease.

  2019cites this paper
• Factors affecting the survival and implantation of human blastocysts following vitrification

  2019cites this paper
• Anti-cancer effect of GV1001 for prostate cancer; function as a ligand of GnRHR.

  2019cites this paper
• Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study.

  2019cites this paper
• The Anti-proliferative Activity of GnRH Through Downregulation of the Akt/ERK Pathways in Pancreatic Cancer

  2019cites this paper
• Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium

  2019cites this paper
• Neuroendocrine Control of the Menstrual Cycle

  2019cites this paper
• Gonadotrophin-releasing hormone receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Double-edged sword of gonadotropin-releasing hormone (GnRH): A novel role of GnRH in the multiple beneficial functions of endometrial stem cells

  2018cites this paper
• Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer

  2018cites this paper
• GnRH in the Human Female Reproductive Axis.

  2018cites this paper
• Breeding in the fat-tailed dunnart following ovarian suppression with the gonadotrophin-releasing hormone agonist Lucrin® Depot.

  2018cites this paper
• GnRH Antagonist Improves Pubertal Cyclophosphamide-Induced Long-Term Testicular Injury in Adult Rats

  2018cites this paper
• The effects of di-2-ethylhexyl phthalate on testicular ultrastructure and hormone-regulated gene expression in male rats.

  2018cites this paper
• Safety of Preventive Oocyte Cryopreservation

  2018cites this paper
• Lepidium sativum Effects on Regulation of Reproduction, Hematological, and Metabolic Indices in Sprague-Dawley Rats

  2018cites this paper
• Uterus-Sparing Treatment Options for the Management of Fibroids

  2018cites this paper
• Differential effects of depot formulations of GnRH agonist leuprorelin and antagonist degarelix on the seminiferous epithelium of the rat testis.

  2018cites this paper
• Preparation of a radiolabeled GnRH-I analogue derivative with 111 In as a new anti-proliferative agent.

  2018cites this paper
• Regulatory Actions of LH and Follicle-Stimulating Hormone on Breast Cancer Cells and Mammary Tumors in Rats

  2018cites this paper
• Changes in body composition and mRNA expression of ghrelin and lipoprotein lipase in rats treated with leuprolide acetate, a GnRH agonist.

  2017cites this paper
• EMIGRATION OF CELLS FROM THE INTRAVASCULAR COMPARTMENT INTO TISSUES

  2017cites this paper